100% secure
Email this product page
Print this page

Influenza A H1N1 Antigen

Influenza A H1N1 Antigen gallery image 1

Purchased this product? Why not be the first to submit a review and upload an image?

  • Influenza A H1N1 Antigen thumbnail image 1
  • Native Influenza A H1N1 Antigen
(Rated 0.0 out of 5 based on 0 customer reviews)
  • Product Type
1 Formats Available
    Product CodeApplicationsDatasheetMSDSPack SizeList PriceQuantity
    PIP021E, Hdatasheet pdfdatasheet pdf1 ml
    Secondary Antibodies
    Negative Isotype Controls
    Useful Reagents
    Positive Controls
    Histology Controls
    More Images
    • Native influenza H1N1 antigen preparation is presented as semi-purified allantoic fluid from chicken eggs infected with New Caladonia 20/99 (H1N1) influenza A virus. Influenza is an acute infection of the respiratory tract caused by the Influenza virus, of which there are several different types. Influenza A causes flu in birds and some mammals and is the most virulent of the influenza types, resulting in the most severe disease. Influenza infection in humans causes chills, fever, pharyngitis, muscle pain, headaches, coughing and weakness. The virus is transmitted through the air by coughs or sneezes or through saliva, nasal secretions, faeces and blood. Infection may occur through direct contact with infected bodily fluid or contaminated surfaces. Influenza viruses mutate rapidly, making vaccines less effective from one season to the next.

      This particular strain of influenza is a reassortant virus that includes genetic components of the H1N1 influenza pandemic swine flu in a culture-adapted virus that has been selected for its qualities as a vaccine-producing strain. The live reassortant virus has passed safety testing in ferrets, in which it is attenuated for pathogenicity relative to wild-type A/California/4/2009 virus. Because A/California/4/2009 is identified as a variant strain of a pandemic virus, live derivatives must be handled under BSL2+ facilities and procedures.

      Native influenza H1N1 antigen preparation (PIP021) contains a high concentration of viral antigens as well as some egg proteins from allantoic fluid.

      Hemaglutination endpoint assay; 33,000 HA Units/ml
    • Intended Use
    • Target Species
    • Product Form
      Inactivated Influenza A H1N1 antigen - liquid.
    • Reconstitution
    • Preparation
      Eggs are infected by injection into the allantoic chamber, incubated for 72 hours, and refrigerated overnight prior to harvest. Allantoic fluids are harvested from the eggs and pooled.

      The antigen preparation is inactivated by gamma radiation.
    • Source
      Influenza strain A/New Caledonia/20/99 (H1N1) cultured in embryonated chicken eggs.
    • Preservative Stabilisers
      None present
    • Activity
      This product has been rendered inactive by standard procedures. However this material should still be handled as infectious and should be disposed of appropriately.
    • Purity
    • Approx. Protein Concentrations
      Total protein concentration 1.60 mg/ml
    • Reagents In The Kit
    • Preparing The Antibody
    • Test Principle
    • Buffer Solution
      Phosphate buffered saline
    • Storage
      Store at -70oC.
      Storage in frost-free freezers is not recommended.
      This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the protein.
    • Shelf Life
      Please see product label.
    • Acknowledgements
    • Regulatory
      For research purposes only
    • This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit the antibody protocols page.

    • Application NameYesNoMin DilutionMax Dilution

    • Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.
    • Technical Advice
    • Recommended Protocol
    • ELISA
    • Immunohistology
    • Histology Positive Control Tissue
    • Immunofluorescence
    • Western Blotting
    • Instructions For Use
      A precipitate may form upon thawing, due to high product concentration. Dilute prior to clarification or other manipulation.

    Additional Influenza A H1N1 Antigen Formats

    Formats Applications Sizes available
    Influenza A H1N1 Antigen : Inactivated Pathogen E, H 1 ml
    • Copyright © 2016 Bio-Rad Antibodies (formerly AbD Serotec)

    Recommended Secondary Antibody

      Recommended Negative Isotype Control

        Useful Reagents

          Recommended Positive Controls

            Histology Controls


              Write your review

              You may also be interested in...

              You May Also Be Interested In...